526 related articles for article (PubMed ID: 3084167)
21. Five years' experience of intrauterine contraception with the Nova-T and the Copper-T-200.
Luukkainen T; Allonen H; Nielsen NC; Nygren KG; Pyörälä T
Am J Obstet Gynecol; 1983 Dec; 147(8):885-92. PubMed ID: 6650625
[TBL] [Abstract][Full Text] [Related]
22. Intrauterine devices. The optimal long-term contraceptive method?
Fortney JA; Feldblum PJ; Raymond EG
J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
[TBL] [Abstract][Full Text] [Related]
23. Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR).
Sivin I; Stern J
Fertil Steril; 1994 Jan; 61(1):70-7. PubMed ID: 8293847
[TBL] [Abstract][Full Text] [Related]
24. Early chorionic activity in women bearing inert IUD, copper IUD and levonorgestrel-releasing IUD.
Videla-Rivero L; Etchepareborda JJ; Kesseru E
Contraception; 1987 Aug; 36(2):217-26. PubMed ID: 3123135
[TBL] [Abstract][Full Text] [Related]
25. Ovarian function during use of a levonorgestrel-releasing IUD.
Barbosa I; Bakos O; Olsson SE; Odlind V; Johansson ED
Contraception; 1990 Jul; 42(1):51-66. PubMed ID: 2117516
[TBL] [Abstract][Full Text] [Related]
26. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
[TBL] [Abstract][Full Text] [Related]
27. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
French R; Van Vliet H; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Helmerhorst F; Guillebaud J
Cochrane Database Syst Rev; 2004; 2004(3):CD001776. PubMed ID: 15266453
[TBL] [Abstract][Full Text] [Related]
28. Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first year of use.
Ratsula K
Contraception; 1987 Dec; 36(6):659-66. PubMed ID: 3128429
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices.
Toivonen J; Luukkainen T; Allonen H
Obstet Gynecol; 1991 Feb; 77(2):261-4. PubMed ID: 1899136
[TBL] [Abstract][Full Text] [Related]
30. New developments in intrauterine devices.
Farr G
Netw Res Triangle Park N C; 1991 Sep; 12(2):9. PubMed ID: 12284281
[TBL] [Abstract][Full Text] [Related]
31. [Levonorgestrel IUD].
Skajaa K; Forman A
Ugeskr Laeger; 1994 Nov; 156(46):6884-7. PubMed ID: 7839510
[TBL] [Abstract][Full Text] [Related]
32. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J
Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007
[TBL] [Abstract][Full Text] [Related]
33. The incidence of actinomyces-like organisms in Papanicolaou-stained smears of copper- and levonorgestrel-releasing intrauterine devices.
Merki-Feld GS; Lebeda E; Hogg B; Keller PJ
Contraception; 2000 Jun; 61(6):365-8. PubMed ID: 10958879
[TBL] [Abstract][Full Text] [Related]
34. Endometrial morphological changes in IUD users: a review.
Sheppard BL
Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
[TBL] [Abstract][Full Text] [Related]
35. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A.
Rowe P; Farley T; Peregoudov A; Piaggio G; Boccard S; Landoulsi S; Meirik O;
Contraception; 2016 Jun; 93(6):498-506. PubMed ID: 26916172
[TBL] [Abstract][Full Text] [Related]
37. The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation.
Faundes A; Alvarez F; Brache V; Tejada AS
Int J Gynaecol Obstet; 1988 Jun; 26(3):429-33. PubMed ID: 2900174
[TBL] [Abstract][Full Text] [Related]
38. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
39. A morphometric study on the endometrial activity of women before and after one year with LNG-IUD in situ.
Gu Z; Zhu P; Luo H; Zhu X; Zhang G; Wu S
Contraception; 1995 Jul; 52(1):57-61. PubMed ID: 8521716
[TBL] [Abstract][Full Text] [Related]
40. Acceptability of IUDs is increasing.
Finger WR; Barr D
Netw Res Triangle Park N C; 1992 Oct; 13(2):27-30. PubMed ID: 12286082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]